Earnings Call
Apr 29, 2026
Q1 FY2026
EPS Estimate
1.78
EPS Actual
1.61
Post-Earnings Close
$217.34
Earnings Reaction
+5.8%
IDEX opened 2026 with results that exceeded its own expectations across every segment, posting 5% organic revenue growth and 10% organic order growth in the first quarter, both ahead of the 1%-2% full-year organic growth guidance the company had entered the year with. Adjusted EBITDA margin expanded 50 basis points year-over-year to 26%, and adjusted EPS came in 'significantly higher' than the guided range, prompting management to raise full-year EPS guidance by $0.20 to a range of $8.35-$8.55. The beat was broad-based, but the story is unmistakably centered on Health & Science Technologies, where 17% organic order growth and 11% organic revenue growth reflect the compounding payoff from deliberate portfolio repositioning into secular growth markets.
Report generated on Apr 29, 2026
AI-generated earnings analysis. Not investment advice.
Chief Executive Officer
The quarter's results reflected a combination of company-specific execution and broader sector dynamics, with management addressing several of the key debates that analysts had flagged heading into the print. Guidance commentary pointed to continued momentum in the core segments, while questions on margins and capital allocation drew more nuanced responses from the leadership team over the course of the call.
The quarter's results reflected a combination of company-specific execution and broader sector dynamics, with management addressing several of the key debates that analysts had flagged heading into the print. Guidance commentary pointed to continued momentum in the core segments, while questions on margins and capital allocation drew more nuanced responses from the leadership team over the course of the call.
The quarter's results reflected a combination of company-specific execution and broader sector dynamics, with management addressing several of the key debates that analysts had flagged heading into the print. Guidance commentary pointed to continued momentum in the core segments, while questions on margins and capital allocation drew more nuanced responses from the leadership team over the course of the call.
Read the full IEX analysis
The complete report, with key themes, analyst Q&A summary, notable quotes, and market context — is free with an account. No password, no card.